Advanced Cancer

我们是谁

  • 1 月 9, 2024
    NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
  • 7 月 24, 2023
    Fc-Engineered Anti-CTLA-4 Monoclonal Antibody Botensilimab in Advanced Cancer
  • 9 月 19, 2022
    An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
  • 4 月 5, 2022
    评估 pING-hHER3FL 的免疫原性
  • 4 月 5, 2022
    BMS-986288单独或与Nivolumab联合治疗晚期实体瘤的免疫疗法研究
  • 4 月 5, 2022
    Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
  • 4 月 5, 2022
    MRTX849 治疗 KRAS G12C 基因突变癌症患者的 1/2 期研究 KRYSTAL-1
  • 4 月 5, 2022
    A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)